CBDA VS CBD. Discussing the Power of New Cannabinoid Compounds
The father of cannabinoid science, Raphael Mechoulem, has just stated that we cannot miss out on the cannabinoid acids molecules associated with cannabinoid compounds. We have been focusing on CBD, CBG, CBC, and CBN, but not their bioactive cousins.
CBDA tinctures contain a closely associated relative to CBD. This infusion includes a potential precursor to cannabidiol, with a unique shape, size, and properties, that boost health and wellness. Similar examples include the CBCA cannabinoid and the CBGA cannabinoid. The benefits can be associated with many broad-spectrum cannabinoids products, as these non-psychoactive alternatives are already partially infused in your daily dose.
Looking Forward: Future Benefits
As distributors lean into stocking these acidic compounds, we are sure to encounter pure extractions containing large amounts of each unique selection. There are a lot of valuable cannabinoid acids compounds, including these variations listed below. Commonly you will find any of the following ingredients:
CBDA (cannabidiolic acid)
CBGA (cannabigerolic acid)
CBCA (cannabichromenic acid)
CBGVA (cannabigerovarinic acid)
CBDVA (cannabidivarinic acid)
These acids are crucial in the healthy development of the plant material. You must remember that the plant nutrients that we value make up the plant body of the flowers we consume. In this case, the acids are typically precursors that lead to the development and anabolism of the plant as they are broken down and transformed. Under heat and time exposure, more acids will be converted to their standard counterparts.
The CBDA benefits can be quite widespread. A potent CBDA oil can carry meaningful, endocannabinoid system connections. This network can help modulate inflammation and reduce pain sensitivity. This acid also has a high affinity for serotonin receptors leading to mood balance and anti-nausea effects. Overall, CBDA is shown to be more bioactive when compared to CBD.
CBGA, or cannabigerolic acid, has promising indications for antibiotic activity. More research needs to be conducted on this product, but the CBGA benefits are sure to breach the range of activity seen with CBG products.
CBCA oil helps to fight inflammation. Just like CBGA, it features antibiotic activity that can’t be ignored. This microbial influence is not unique to the acid family, by the way. The standard hemp cannabinoids can carry similar properties to clean the gut and associated pathways.
CBGVA and CBDVA are still being explored. Remember, that research on the cannabis subject has been scarce for a long time. Legal constraints have prevented a fair investigation into this globally renowned plant.
The CBDA Promise
With what was written above, one line might have slipped out of focus. CBDA is more bioactive when compared to CBD. It also creates a unique impact on the mind and body. CBD and CBDA both influence serotonin receptors, but CBDA does this at a higher rate. Serotonin receptor stimulation fights depression, alleviates anxiety, and combats nausea.
The father of molecular cannabis and endocannabinoid research is telling us to search in this direction. Storing, extraction, and administration of acidic cannabinoids are all figured out. The technique is valid, and the products likely have the same safety profile as the now conventional cannabinoid products. All of these acids will have their moment to shine, and we look forward to the day when a select spectrum of these acids, or other hemp nutrients, could be refined into unique products for our enjoyment and health.
When Will These Products Be Available?
Cannabinoid acid products are available for sale and purchase now. The World Health Organisation branch of the United Nations indicated that any cannabinoid infusion containing under 0.2% THC should be sold without restriction. None of these acidic compounds will breach this regulation, and they will never be psychoactive.
CBDA products seem highly effective, leading curious and sharp minds to research their role in human health. Each of these compounds is a key that unlocks an understanding of a portion of the total cannabis plant potential. Every time one of these items is understood, all the way from benefits to their safety profile, they can be added to store shelves as effectively as amino acids and their neuro-communicating precursors.
Another aspect of this work that remains appealing is the fact that the side effects are next to none. That is why the cannabinoid game remains on the market. You may hear of minor reactions, but they are not substantiated by long term studies and are never implicated in lasting health concerns. Instead, you hear about cannabinoids, including CBD, helping with long-lasting issues. Plant therapy is a beautiful way to bolster your health using an easy to engage regimen.
While acceptance is on the rise, studies are beginning to agree with the long-held belief that cannabis had an active safety profile. Adverse reactions are scarce and difficult to find, mainly when there is no significant amount of THC to be considered. These acids will become commonplace, and in reality, they are already being distributed in broad-spectrum cannabinoid compounds, undoubtedly providing their incredibly powerful health benefits.
Cannabis medicinals are spreading across the world with great success. United States of America programs are succeeding. Canadian companies are thriving with flowers and oils. They will be stepping into edible production in a year or two, most likely. Mexican recreational cannabis is coming at you live, while European medical programs are popping up left and right.
Because cannabis is a part of human culture. Prohibition started popping up in the 1930s. When modern medical understanding reached a particular pharmaceutical style of thought, professionals did not want the cannabis competition. Paper mills also didn’t want the competition of hemp production going forward. So stigma was created, launched at cannabis, and all aspects of the plant were made highly illegal.
Now, we are stepping back into a casual relationship with cannabis, where it can be consumed rather freely. So long as medical patients get access, so long as cheap CBD oils remain available, we will be well on our way to better health. In the meantime, as things lighten up in response to the World Health Organisation’s request to deschedule cannabis for research, we will be giddy and looking forward to seeing the latest reports on new cannabinoid components. Undoubtedly, in a short time from now, we will be posting a fresh article, happily demystifying the potential of these revolutionary compounds.